SFX by Ex Libris Inc.

Users interested in this article also expressed an interest in the following:
description	1.	Ferry, G. "Characterization of novel Checkpoint kinase 1 inhibitors by in vitro assays and in human cancer cells treated with topoisomerase inhibitors." Life sciences 89.7-8 (2011): 259-268.
description	2.	"Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models." Clinical cancer research. 25.7: 2278-2289.
description	3.	Saijo, N. "Preclinical and clinical trials of topoisomerase inhibitors." Annals of the New York Academy of Sciences 922 (2000): 92-9.
description	4.	Tabassum, S. "Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase I inhibitor." Dalton transactions 41.16 (2012): 4955-.
description	5.	BARKER, D. "ADENOVIRUS PROTEINS FROM BOTH E1B READING FRAMES ARE REQUIRED FOR TRANSFORMATION OF RODENT CELLS BY VIRAL-INFECTION AND DNA TRANSFECTION." Virology 156.1 (1987): 107-121.
description	6.	Khuri, F.R. R. "A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer." Nature medicine 6.8 (2000): 879-885.

Select All Clear All Save Citations

Science [0036-8075] Finkel, E yr:1999